CommercialCoverageHigh impact
State and School Employees' Health Insurance Plan - Immunoglobulin Therapy
Blue Cross & Blue Shield of Mississippi·Neurology, Rheumatology, Hematology +4 more·Medical Policy
We identified it
Jun 20, 2026
Summary
State and School Employees' Health Insurance Plan updated coverage for immunoglobulin therapy products. Multiple IVIG/SCIG products are now non-covered (including Alyglo, Asceniv, Bivigam, etc.) while only specific formulary agents are covered (Gammagard Liquid, Gammaked, Gamunex-C, Octagam, Privigen for IVIG; Cutaquig, Hizentra, Xembify for SCIG). Strict medical necessity criteria must be met for coverage.
Action Required
Immediately: Billing team must update prior authorization processes to ensure only formulary immunoglobulin products are used (IVIG: Gammagard Liquid, Gammaked, Gamunex-C, Octagam, Privigen; SCIG: Cutaquig, Hizentra, Xembify). Verify all medical necessity criteria are documented before billing. Non-formulary products (Alyglo, Asceniv, Bivigam, Cuvitru, Flebogamma DIF, Gammagard S/D, Gammaplex, GamaSTAN, Hyqvia, Panzyga, Yimmugo) will be denied. Providers must document specific qualifying conditions and failed prior treatments per policy requirements.